Concepts (344)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 24 | 2025 | 125 | 5.830 |
Why?
|
| Air Pollution | 18 | 2024 | 78 | 4.310 |
Why?
|
| Maternal Exposure | 22 | 2025 | 149 | 3.660 |
Why?
|
| Particulate Matter | 19 | 2025 | 92 | 3.640 |
Why?
|
| Environmental Exposure | 22 | 2025 | 290 | 3.500 |
Why?
|
| Occupational Exposure | 27 | 2022 | 136 | 3.310 |
Why?
|
| Environmental Monitoring | 25 | 2022 | 102 | 3.120 |
Why?
|
| Texas | 37 | 2025 | 3614 | 1.840 |
Why?
|
| Metals, Heavy | 3 | 2021 | 26 | 1.840 |
Why?
|
| Stillbirth | 3 | 2019 | 103 | 1.690 |
Why?
|
| Cyclonic Storms | 4 | 2021 | 78 | 1.610 |
Why?
|
| Industry | 10 | 2021 | 29 | 1.580 |
Why?
|
| Metals | 4 | 2023 | 67 | 1.560 |
Why?
|
| Arsenic | 4 | 2023 | 48 | 1.420 |
Why?
|
| Community-Based Participatory Research | 2 | 2023 | 63 | 1.400 |
Why?
|
| Residence Characteristics | 6 | 2020 | 292 | 1.380 |
Why?
|
| Disasters | 3 | 2021 | 101 | 1.350 |
Why?
|
| Mexican Americans | 6 | 2018 | 166 | 1.270 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2024 | 232 | 1.240 |
Why?
|
| Premature Birth | 5 | 2018 | 415 | 1.240 |
Why?
|
| Environmental Pollutants | 6 | 2018 | 81 | 1.230 |
Why?
|
| Ozone | 3 | 2019 | 20 | 1.170 |
Why?
|
| Stress, Psychological | 6 | 2021 | 561 | 1.110 |
Why?
|
| Oil and Gas Industry | 2 | 2018 | 5 | 1.100 |
Why?
|
| Pregnancy | 32 | 2025 | 7571 | 1.070 |
Why?
|
| Environmental Health | 3 | 2023 | 21 | 0.980 |
Why?
|
| Nitrogen Dioxide | 7 | 2025 | 26 | 0.860 |
Why?
|
| Recycling | 2 | 2020 | 5 | 0.810 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.720 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 7 | 2022 | 79 | 0.710 |
Why?
|
| Volatile Organic Compounds | 2 | 2020 | 13 | 0.710 |
Why?
|
| Deer | 1 | 2021 | 15 | 0.680 |
Why?
|
| Population Dynamics | 2 | 2019 | 29 | 0.670 |
Why?
|
| Adult | 46 | 2025 | 31629 | 0.670 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 150 | 0.660 |
Why?
|
| Disaster Planning | 1 | 2021 | 63 | 0.660 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 629 | 0.650 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 17 | 0.640 |
Why?
|
| Fires | 1 | 2020 | 9 | 0.630 |
Why?
|
| Benzene | 7 | 2020 | 24 | 0.620 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 14 | 0.610 |
Why?
|
| Humans | 98 | 2025 | 131406 | 0.610 |
Why?
|
| Temperature | 1 | 2019 | 294 | 0.570 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 111 | 0.570 |
Why?
|
| Natural Gas | 1 | 2018 | 5 | 0.560 |
Why?
|
| Young Adult | 23 | 2023 | 10081 | 0.550 |
Why?
|
| Female | 66 | 2025 | 71032 | 0.550 |
Why?
|
| Logistic Models | 14 | 2019 | 1831 | 0.540 |
Why?
|
| Trace Elements | 1 | 2017 | 21 | 0.510 |
Why?
|
| Butadienes | 1 | 2016 | 22 | 0.500 |
Why?
|
| Hazardous Substances | 5 | 2015 | 17 | 0.490 |
Why?
|
| Urban Population | 6 | 2019 | 281 | 0.490 |
Why?
|
| Models, Statistical | 7 | 2025 | 492 | 0.480 |
Why?
|
| Social Class | 2 | 2017 | 210 | 0.480 |
Why?
|
| Leukemia | 1 | 2019 | 375 | 0.470 |
Why?
|
| Community Participation | 1 | 2015 | 43 | 0.460 |
Why?
|
| Multilingualism | 1 | 2015 | 35 | 0.460 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 638 | 0.460 |
Why?
|
| Inhalation Exposure | 5 | 2020 | 38 | 0.450 |
Why?
|
| Surveys and Questionnaires | 9 | 2021 | 4033 | 0.440 |
Why?
|
| Air Pollutants, Occupational | 7 | 2006 | 24 | 0.430 |
Why?
|
| Hypertension | 3 | 2018 | 1357 | 0.430 |
Why?
|
| Birth Weight | 6 | 2025 | 346 | 0.420 |
Why?
|
| Models, Theoretical | 7 | 2015 | 365 | 0.420 |
Why?
|
| Occupational Diseases | 6 | 2016 | 78 | 0.420 |
Why?
|
| Case-Control Studies | 12 | 2019 | 3448 | 0.410 |
Why?
|
| Pilot Projects | 5 | 2020 | 1450 | 0.410 |
Why?
|
| Birth Certificates | 3 | 2019 | 13 | 0.380 |
Why?
|
| Risk Assessment | 7 | 2021 | 3691 | 0.370 |
Why?
|
| Infant, Newborn | 16 | 2025 | 8584 | 0.360 |
Why?
|
| Cohort Studies | 12 | 2022 | 5119 | 0.360 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 55 | 0.350 |
Why?
|
| Legionellosis | 1 | 2011 | 4 | 0.350 |
Why?
|
| Linear Models | 7 | 2017 | 695 | 0.350 |
Why?
|
| Water Supply | 2 | 2004 | 26 | 0.350 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 896 | 0.340 |
Why?
|
| Mercury | 2 | 2001 | 31 | 0.340 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 840 | 0.340 |
Why?
|
| Water Pollutants, Chemical | 2 | 2004 | 37 | 0.330 |
Why?
|
| Bayes Theorem | 7 | 2025 | 306 | 0.330 |
Why?
|
| Nickel | 2 | 2001 | 21 | 0.330 |
Why?
|
| Cities | 2 | 2020 | 53 | 0.320 |
Why?
|
| Polybrominated Biphenyls | 2 | 2007 | 5 | 0.310 |
Why?
|
| Particle Size | 4 | 2022 | 137 | 0.310 |
Why?
|
| Asthma | 7 | 2014 | 926 | 0.310 |
Why?
|
| Odds Ratio | 10 | 2016 | 1235 | 0.300 |
Why?
|
| Gestational Age | 5 | 2022 | 1220 | 0.300 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 314 | 0.300 |
Why?
|
| Respiratory Tract Diseases | 3 | 2020 | 80 | 0.300 |
Why?
|
| Disinfection | 2 | 2011 | 26 | 0.290 |
Why?
|
| Agriculture | 2 | 2006 | 32 | 0.290 |
Why?
|
| Cognition Disorders | 1 | 2013 | 565 | 0.290 |
Why?
|
| Pesticides | 3 | 2022 | 33 | 0.290 |
Why?
|
| Risk Factors | 17 | 2019 | 10947 | 0.280 |
Why?
|
| Male | 38 | 2023 | 65110 | 0.260 |
Why?
|
| Mining | 4 | 2010 | 8 | 0.260 |
Why?
|
| Metallurgy | 4 | 2000 | 6 | 0.260 |
Why?
|
| United States | 24 | 2019 | 11784 | 0.250 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 34 | 0.250 |
Why?
|
| Aerosols | 3 | 2022 | 60 | 0.250 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 12 | 0.240 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 60 | 0.240 |
Why?
|
| Prevalence | 11 | 2018 | 2692 | 0.230 |
Why?
|
| Biomarkers | 6 | 2017 | 3400 | 0.230 |
Why?
|
| Styrene | 4 | 2001 | 4 | 0.220 |
Why?
|
| Chemical Industry | 4 | 2001 | 7 | 0.220 |
Why?
|
| Risk | 3 | 2019 | 739 | 0.210 |
Why?
|
| SEER Program | 3 | 2014 | 210 | 0.210 |
Why?
|
| Trihalomethanes | 1 | 2004 | 5 | 0.210 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 1809 | 0.210 |
Why?
|
| Cleft Lip | 2 | 2017 | 190 | 0.200 |
Why?
|
| United States Environmental Protection Agency | 3 | 2019 | 7 | 0.200 |
Why?
|
| Cleft Palate | 2 | 2017 | 219 | 0.200 |
Why?
|
| Data Collection | 4 | 2023 | 371 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2004 | 1223 | 0.200 |
Why?
|
| Cobalt | 1 | 2022 | 17 | 0.190 |
Why?
|
| Tungsten | 1 | 2022 | 5 | 0.190 |
Why?
|
| Health Surveys | 3 | 2020 | 262 | 0.180 |
Why?
|
| Middle Aged | 20 | 2021 | 28808 | 0.180 |
Why?
|
| Glyoxylates | 1 | 2001 | 4 | 0.180 |
Why?
|
| Mandelic Acids | 1 | 2001 | 6 | 0.180 |
Why?
|
| Toluene | 3 | 2010 | 11 | 0.170 |
Why?
|
| Child | 10 | 2024 | 26224 | 0.170 |
Why?
|
| Xylenes | 3 | 2010 | 13 | 0.170 |
Why?
|
| Benzene Derivatives | 3 | 2010 | 20 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 167 | 0.170 |
Why?
|
| Soil | 1 | 2021 | 76 | 0.170 |
Why?
|
| China | 1 | 2021 | 287 | 0.170 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 8 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 238 | 0.170 |
Why?
|
| Floods | 1 | 2021 | 22 | 0.170 |
Why?
|
| Exercise | 2 | 2017 | 865 | 0.170 |
Why?
|
| Women, Working | 2 | 2017 | 8 | 0.170 |
Why?
|
| Spinal Dysraphism | 3 | 2015 | 279 | 0.160 |
Why?
|
| Reproducibility of Results | 5 | 2007 | 2984 | 0.160 |
Why?
|
| Soot | 1 | 2020 | 14 | 0.160 |
Why?
|
| Food Contamination | 3 | 2007 | 28 | 0.160 |
Why?
|
| Cadmium | 1 | 2020 | 33 | 0.160 |
Why?
|
| Vehicle Emissions | 2 | 2022 | 21 | 0.160 |
Why?
|
| Styrenes | 3 | 1996 | 6 | 0.160 |
Why?
|
| Feasibility Studies | 4 | 2017 | 827 | 0.160 |
Why?
|
| Weather | 1 | 2019 | 16 | 0.150 |
Why?
|
| Regression Analysis | 5 | 2014 | 773 | 0.150 |
Why?
|
| RNA, Viral | 1 | 2021 | 513 | 0.150 |
Why?
|
| Aged | 14 | 2021 | 21216 | 0.150 |
Why?
|
| Universities | 1 | 2020 | 122 | 0.150 |
Why?
|
| Urban Health | 1 | 2019 | 85 | 0.150 |
Why?
|
| Oil and Gas Fields | 1 | 2019 | 9 | 0.150 |
Why?
|
| Sister Chromatid Exchange | 2 | 1996 | 15 | 0.150 |
Why?
|
| Child, Preschool | 8 | 2024 | 15037 | 0.150 |
Why?
|
| Adolescent | 13 | 2021 | 20902 | 0.140 |
Why?
|
| Registries | 3 | 2019 | 1598 | 0.140 |
Why?
|
| Analysis of Variance | 5 | 2001 | 954 | 0.140 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 331 | 0.140 |
Why?
|
| Drinking Behavior | 1 | 1998 | 9 | 0.140 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1416 | 0.140 |
Why?
|
| Hypersensitivity | 1 | 2021 | 231 | 0.140 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 40 | 0.140 |
Why?
|
| Geography, Medical | 1 | 2017 | 17 | 0.130 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2142 | 0.130 |
Why?
|
| Occupations | 1 | 2017 | 19 | 0.130 |
Why?
|
| Workplace | 2 | 2015 | 81 | 0.130 |
Why?
|
| Fluorocarbons | 1 | 2017 | 69 | 0.130 |
Why?
|
| Retrospective Studies | 7 | 2025 | 17629 | 0.130 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 19 | 0.130 |
Why?
|
| Fetal Development | 3 | 2022 | 128 | 0.130 |
Why?
|
| Molecular Weight | 1 | 2017 | 297 | 0.130 |
Why?
|
| DNA Adducts | 1 | 1996 | 71 | 0.120 |
Why?
|
| Serum Albumin | 1 | 1996 | 110 | 0.120 |
Why?
|
| Neural Tube Defects | 2 | 2010 | 380 | 0.120 |
Why?
|
| Phthalic Acids | 1 | 2016 | 11 | 0.120 |
Why?
|
| Reproductive History | 1 | 1995 | 10 | 0.120 |
Why?
|
| Lead | 1 | 1995 | 24 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1169 | 0.110 |
Why?
|
| International Agencies | 1 | 2015 | 29 | 0.110 |
Why?
|
| Publications | 1 | 2015 | 36 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 80 | 0.110 |
Why?
|
| Menopause | 1 | 1995 | 87 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2016 | 179 | 0.110 |
Why?
|
| Cause of Death | 2 | 2014 | 510 | 0.110 |
Why?
|
| Chlamydia trachomatis | 1 | 2014 | 30 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 6911 | 0.110 |
Why?
|
| Focus Groups | 1 | 2015 | 227 | 0.110 |
Why?
|
| Cross-Sectional Studies | 7 | 2016 | 3832 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 998 | 0.110 |
Why?
|
| Motor Activity | 2 | 2015 | 508 | 0.110 |
Why?
|
| Occupational Health | 3 | 2010 | 46 | 0.110 |
Why?
|
| Azithromycin | 1 | 2014 | 45 | 0.110 |
Why?
|
| Juvenile Delinquency | 1 | 2014 | 25 | 0.110 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 53 | 0.110 |
Why?
|
| Environment Design | 1 | 2014 | 16 | 0.110 |
Why?
|
| Prisoners | 1 | 2014 | 39 | 0.110 |
Why?
|
| Nutrition Surveys | 5 | 2016 | 327 | 0.110 |
Why?
|
| North America | 3 | 2000 | 256 | 0.100 |
Why?
|
| Vitamin D | 1 | 2016 | 189 | 0.100 |
Why?
|
| Smoking | 3 | 1996 | 926 | 0.100 |
Why?
|
| Doxycycline | 1 | 2014 | 115 | 0.100 |
Why?
|
| Iron | 1 | 2017 | 309 | 0.100 |
Why?
|
| Europe | 3 | 2000 | 372 | 0.100 |
Why?
|
| Uncertainty | 1 | 2014 | 96 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2016 | 196 | 0.100 |
Why?
|
| Population Surveillance | 3 | 2012 | 397 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1386 | 0.100 |
Why?
|
| Insurance Claim Reporting | 1 | 2012 | 7 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2015 | 156 | 0.100 |
Why?
|
| Poverty | 2 | 2015 | 455 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2012 | 41 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 348 | 0.090 |
Why?
|
| Infant | 7 | 2024 | 13292 | 0.090 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2003 | 16 | 0.090 |
Why?
|
| Iron, Dietary | 1 | 2012 | 15 | 0.090 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 2081 | 0.090 |
Why?
|
| Maintenance | 1 | 2011 | 1 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2002 | 41 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 389 | 0.090 |
Why?
|
| Gastroschisis | 1 | 2012 | 58 | 0.090 |
Why?
|
| Health Personnel | 2 | 2006 | 549 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 128 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 34321 | 0.080 |
Why?
|
| Equipment Contamination | 1 | 2011 | 42 | 0.080 |
Why?
|
| Age Factors | 4 | 2015 | 2869 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 547 | 0.080 |
Why?
|
| Demography | 3 | 2007 | 243 | 0.080 |
Why?
|
| Anencephaly | 1 | 2010 | 11 | 0.080 |
Why?
|
| Time Factors | 5 | 2001 | 6272 | 0.080 |
Why?
|
| Gasoline | 2 | 2022 | 4 | 0.080 |
Why?
|
| Parity | 2 | 2007 | 84 | 0.080 |
Why?
|
| Creatinine | 2 | 2001 | 399 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2014 | 854 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5267 | 0.070 |
Why?
|
| Research Design | 2 | 2007 | 722 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2022 | 6481 | 0.070 |
Why?
|
| Manufactured Materials | 2 | 1998 | 2 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2025 | 684 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 361 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2003 | 1513 | 0.070 |
Why?
|
| Dementia | 1 | 2013 | 433 | 0.070 |
Why?
|
| Incidence | 4 | 2023 | 3340 | 0.070 |
Why?
|
| Japan | 2 | 1998 | 173 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 441 | 0.070 |
Why?
|
| Cognition | 2 | 2024 | 842 | 0.070 |
Why?
|
| Michigan | 1 | 2007 | 47 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2969 | 0.070 |
Why?
|
| South Carolina | 1 | 2006 | 10 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 1006 | 0.060 |
Why?
|
| Diet | 2 | 2011 | 1119 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 432 | 0.050 |
Why?
|
| Chlorine | 1 | 2004 | 15 | 0.050 |
Why?
|
| Disinfectants | 1 | 2004 | 29 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1488 | 0.050 |
Why?
|
| Water Purification | 1 | 2004 | 19 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2011 | 947 | 0.050 |
Why?
|
| Fishes | 1 | 2003 | 33 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2566 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2010 | 271 | 0.050 |
Why?
|
| Alloys | 1 | 2022 | 17 | 0.050 |
Why?
|
| Antimony | 1 | 2022 | 14 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1541 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2022 | 71 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 227 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 44 | 0.050 |
Why?
|
| Seasons | 1 | 2004 | 333 | 0.050 |
Why?
|
| Maximum Allowable Concentration | 1 | 2001 | 6 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2025 | 278 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2001 | 17 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 337 | 0.040 |
Why?
|
| Transients and Migrants | 1 | 2001 | 30 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2001 | 75 | 0.040 |
Why?
|
| Italy | 1 | 2001 | 133 | 0.040 |
Why?
|
| Sociological Factors | 1 | 2021 | 9 | 0.040 |
Why?
|
| Laboratories | 1 | 2022 | 84 | 0.040 |
Why?
|
| Medicaid | 2 | 2014 | 251 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1891 | 0.040 |
Why?
|
| Western Australia | 1 | 2000 | 6 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 31 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 496 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 418 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2010 | 1682 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1344 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 1998 | 19 | 0.040 |
Why?
|
| Baths | 1 | 1998 | 15 | 0.030 |
Why?
|
| Norway | 1 | 2017 | 29 | 0.030 |
Why?
|
| Menstruation | 1 | 2017 | 26 | 0.030 |
Why?
|
| Carcinogenicity Tests | 1 | 1996 | 18 | 0.030 |
Why?
|
| Biotransformation | 1 | 1996 | 53 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 621 | 0.030 |
Why?
|
| Employment | 1 | 2017 | 71 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 96 | 0.030 |
Why?
|
| Time | 1 | 1996 | 96 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 234 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 59 | 0.030 |
Why?
|
| Bias | 1 | 1996 | 144 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 61 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 198 | 0.030 |
Why?
|
| Workload | 1 | 2016 | 153 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 31 | 0.030 |
Why?
|
| Posture | 1 | 2015 | 136 | 0.030 |
Why?
|
| Income | 1 | 1995 | 135 | 0.030 |
Why?
|
| Postmenopause | 1 | 1995 | 149 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 40 | 0.030 |
Why?
|
| Food-Processing Industry | 1 | 1993 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 681 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 200 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 390 | 0.020 |
Why?
|
| Public Health | 1 | 2015 | 276 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1409 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 58 | 0.020 |
Why?
|
| Meat | 1 | 2012 | 44 | 0.020 |
Why?
|
| Vitamin E | 1 | 2012 | 63 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 387 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 61 | 0.020 |
Why?
|
| Heme | 1 | 2012 | 55 | 0.020 |
Why?
|
| DNA | 1 | 1996 | 1443 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 463 | 0.020 |
Why?
|
| Job Description | 1 | 2010 | 9 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1522 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 81 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 69 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 418 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 329 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 1404 | 0.020 |
Why?
|
| Construction Materials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1404 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 439 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 379 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 791 | 0.020 |
Why?
|
| Life Style | 2 | 2003 | 444 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1589 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 556 | 0.020 |
Why?
|
| Mass Screening | 1 | 2014 | 825 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 286 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12923 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2146 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 448 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 838 | 0.020 |
Why?
|
| Great Lakes Region | 1 | 2003 | 1 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 179 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4516 | 0.010 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 1997 | 3 | 0.010 |
Why?
|
| Ventilation | 1 | 1993 | 7 | 0.010 |
Why?
|
| Netherlands | 1 | 1993 | 55 | 0.010 |
Why?
|
| United Kingdom | 1 | 1993 | 252 | 0.010 |
Why?
|
| Models, Biological | 1 | 1993 | 1390 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1990 | 359 | 0.000 |
Why?
|